Logo - springer
Slogan - springer

Medicine | Trials

Trials
BioMed Central

Trials

Editors-in-Chief: D.G. Altman; C.D. Furberg; J. Grimshaw; P. Rothwell

ISSN: 1745-6215 (electronic version)

Journal no. 13063

BioMed Central

Open access BioMed Central
  • About this journal

  • High visibility of your research – 2,000,000 accesses in 2013
  • Supports transparency by publishing all aspects of trials - including research, methodology and protocols
  • Promotes registration of all trials and sharing of clinical data

Trials is an open access, peer-reviewed, online journal that encompasses all aspects of the performance and findings of randomized controlled trials in health. We publish articles on general trial methodology as well as protocols, commentaries and traditional results papers - regardless of outcome or significance of findings.

Related subjects » Biomedical Sciences - Life Sciences, Medicine & Health - Medicine

Impact Factor: 2.117 (2013) * 

Journal Citation Reports®, Thomson Reuters

Abstracted/Indexed in 

PubMed/Medline, PubMedCentral, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO, CSA, Academic OneFile, Academic Search, CSA Environmental Sciences, Current Contents, Health Reference Center Academic, OCLC, SCImago, Summon by ProQuest, Thomson Reuters (ISI)

Read This journal on BioMed Central

For authors and editors


  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 2.117
  • Aims and Scope

    Aims and Scope

    Close

    Trials is an open access, peer-reviewed, online journal that encompasses all aspects of the performance and findings of randomized controlled trials in health. We publish articles on general trial methodology as well as protocols, commentaries and traditional results papers - regardless of outcome or significance of findings. Trials aims to experiment with, and refine, innovative approaches to improving communication about trials. We are keen to move beyond publishing traditional trial results articles (although these are included). We believe this journal represents an exciting opportunity to advance the science and reporting of trials. Making all its content open access and not retaining copyright, Trials offers a way to make data both freely available and highly visible to trialists worldwide; this will benefit the impact of your publication among peers and societies. The journal has unrestricted space and takes advantage of all the technical possibilities available for electronic publishing. To date, journals have focused on reporting the results of trials, with very little coverage of why and how they are conducted. Reports of trials have been restricted both by authors and editors &mdash both parties often select only a subset of the outcomes measured, while the latter often impose word limits on the articles published making it difficult to communicate the lessons learnt from conducting the trial, let alone include adequate details of how the trial was conducted. The Internet offers both unlimited space and interactivity, and we are keen to harness these attributes. For instance, trialists are able to provide the detail required to be a true scientific record and do more to make the article's message comprehensible to a variety of reader groups. They are able to communicate not only all outcome measures, as well as varying analyses and interpretations, but also in-depth descriptions of what they did and what they learnt. This sharing of direct experience is fundamental to improving the quality and conduct of trials worldwide.
  • Submit Online
  • English Language Editing

    English Language Editing

    Close

  • Author Academy: Training for Authors